NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NEI E-050-2015-0-US-08 RP2 AND RPGR VECTORS FOR TREATING X-LINKED RETINITIS PIGMENTOSA US National Stage 15/556,746 10646588 Issued PDF
NCI E-104-2013-0-US-04 ANTI-276 POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS US CON 15/699,419 10604583 Issued PDF
NIAID E-253-2011-3-US-13 NEUTRALIZING GP41 ANTIBODIES AND THEIR USE US DIV 15/699,902 10047148 Issued PDF
NHLBI E-211-2018-2-US-01 Methods Of Inhibiting Viruses Using Compositions Targeting TSG101-Ubiquitin Interaction US 62/555,947 Abandoned
NHGRI E-149-2017-0-US-01 Biomarkers of Organic Acidemias US 62/556,071 Abandoned
NCI E-016-2016-0-PCT-02 SYNERGISTIC ANTI-TUMOR EFFECT OF HMG PROTEIN IN COMBINATION WITH ANTI-CD4 ANTIBODY OR IMMUNE CHECKPOINT REGULATOR PCT PCT PCT/JP2017/032351 Expired
NCI E-265-2011-0-AU-14 Anti-CD22 Chimeric Antigen Receptors AU DIV 2017225049 Abandoned
NCI E-241-2016-0-US-01 Micro-Dose Calibrator US 62/554,980 Abandoned
NIAID E-228-2016-1-CN-05 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof CN National Stage 201780066267.2 Issued
NIAID E-228-2016-1-IN-06 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof IN National Stage 201917007726 Issued
NIAID E-228-2016-1-IL-09 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof IL National Stage 265121 Issued
NIAID E-228-2016-1-JP-11 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof JP National Stage 2019-512267 Issued
NCI E-098-2015-0-US-05 DISPLAY PLATFORM FROM BACTERIAL SPORE COAT PROTEINS US National Stage 15/555,283 10813993 Issued PDF
NCI E-174-2011-0-US-24 PSEUDOMONAS EXOTOXIN A WITH LESS IMMUNOGENIC T CELL AND/OR B CELL EPITOPES US DIV 15/693,705 10428119 Issued PDF
NIAID E-228-2016-1-PCT-01 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof PCT PCT COMB PCT/US2017/049894 Expired
NCI E-168-2011-0-US-08 METHODS AND COMPOSITIONS FOR INHIBITING POLYOMAVIRUS-ASSOCIATED PATHOLOGY US DIV 15/694,567 Abandoned
NIAID E-228-2016-1-EP-03 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof EP National Stage 17768316.6 Pending
NIAID E-228-2016-1-BR-08 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof BR National Stage BR112019004189-3 Pending
NIAID E-228-2016-1-CA-04 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof CA National Stage 3035443 Pending
NIAID E-228-2016-1-SG-13 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof SG DIV 10201912944Q Pending
NIAID E-228-2016-1-SG-12 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof SG National Stage 11201901790Y Pending
NCI E-040-2012-0-US-24 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 15/692,473 10767184 Issued PDF
NICHD E-010-2010-0-US-05 Method For The Detecting Hematoma, Portable Detection and Discrimination Device and Related Systems and Apparatuses US CON 15/691,661 11800983 Issued PDF
NCI E-148-2011-0-IL-14 Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer IL DIV 254201 Issued
NCI E-267-2016-0-EP-04 Synthetic Self-assembling Peptide Antagonists Of Human CCR3 For The Treatment Of Inflammatory Diseases EP National Stage 16749945.8 Issued
NIAID E-168-2016-0-PCT-02 TISSUE CLEARING METHOD PCT PCT PCT/US2017/049133 Expired
NCI E-168-2017-0-US-01 RADIOLIGAND FOR ASSESSING HUMAN TRPV1 STRUCTURE-ACTIVITY RELATIONSHIPS AND METHOD OF USE US 62/551,436 Abandoned
NCATS E-232-2017-0-US-01 Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders US 62/550,826 Abandoned
NCI E-214-2016-0-PCT-02 HUMAN SINGLE DOMAIN ANTIBODIES TARGETING CD16A TO MEDIATE ADCC PCT PCT PCT/US2017/048721 Abandoned
NHLBI E-222-2022-0-US-01 Multi Lumen Independently Deflectable Catheter US 62/550,347 Expired
NHLBI E-211-2018-1-US-01 Methods Of Inhibiting Viruses Using Compositions Targeting TSG101-Ubiquitin Interaction US 62/550,253 Abandoned
NHGRI E-092-2014-1-US-05 SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS US National Stage 15/553,561 10493087 Abandoned PDF
NIAID E-239-2014-0-US-06 MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE US National Stage 15/553,466 10301377 Issued PDF
NIAMS E-189-2017-0-US-01 Regulatory Genetic Variants of IL1RN US 62/549,746 Abandoned
NCI E-143-2017-0-US-01 Conformational Restriction Of Cyanine Fluorophores In Far-red And Near-lR Range US 62/549,566 Abandoned
NCI E-230-2012-0-AU-12 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 AU DIV 2017219019 Issued
NIAID E-236-2018-0-KR-01 Monoclonal Antibody Against Spike Protein Of Middle East Respiratory Syndrome Coronavirus And Uses Thereof KR ORD 10-2017-0106836 Issued
NIBIB E-006-2016-0-PCT-02 Systems and Methods for Instant Total Internal Reflection Fluorescence/Structured Illumination Microscopy PCT PCT PCT/US2017/048234 Expired
NIBIB E-006-2016-0-CN-05 Systems and Methods for Instant Total Internal Reflection Fluorescence/Structured Illumination Microscopy CN National Stage 201780030158.5 Pending
NCI E-021-2018-0-PCT-02 INSTRUMENTED BIOPSY PROBE PCT PCT PCT/US2017/048047 Expired
NCI E-021-2018-0-US-03 INSTRUMENTED BIOPSY PROBE US ORD 15/683,381 Abandoned
NIAID E-239-2014-0-SA-05 MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE SA National Stage 517382168 Abandoned
NEI E-165-2017-0-US-01 Compositions and Methods To Protect Mammalian Tissue Against Cold And Other Metabolic Stresses US 62/547,945 Abandoned
NIDDK E-225-2017-0-US-01 PEPTIDE NUCLEIC ACID-COATED GOLD NANOPARTICLES FOR SIGNAL DETECTION AND AMPLIFICATION IN MICROFLUIDIC DIAGNOSTICS US 62/547,489 Abandoned
NCI E-344-2013-0-US-10 TEM8 Antibodies and Their Use in Treatment and Detection of Tumors US CON 15/680,177 10196443 Issued PDF
NHLBI E-175-2017-0-US-01 Hybrid CT System With Additional Detectors In Close Proximity To The Body US 62/546,639 Abandoned
NCATS E-262-2016-0-LT-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS LT EP 17821743.6 Abandoned
NCATS E-262-2016-0-LU-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS LU EP 17821743.6 Abandoned
NCATS E-262-2016-0-NL-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS NL EP 17821743.6 Abandoned
NCATS E-262-2016-0-LV-01 COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES, AND METHODS FOR PREPARING COMPOUNDS LV EP 17821743.6 Abandoned